Sonelokimab [1414386-05-2]

MedChem Express

Sonelokimab [1414386-05-2]

10

1414386-05-2

Research Use Only

99.81

Sonelokimab (ALX 0761) is a trivalent bispecific nanobody composed of camel derived humanized IL-17F antibodies, IL-17A/F antibodies, and serum albumin VHH antibodies. Sonelokimab can prolong the plasma half-life by binding to human serum albumin. Sonelokimab can be used for research on rheumatoid arthritis and psoriasis[1][2][3][4].

-80°C

41116161